Apr 24 |
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Apr 18 |
Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value
|
Apr 15 |
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
|
Apr 4 |
Caribou Biosciences received IND clearance from FDA for its lupus treatment
|
Apr 4 |
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
|
Apr 1 |
With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns
|
Mar 14 |
All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy
|
Mar 13 |
11 Oversold NASDAQ Stocks To Buy Right Now
|
Mar 13 |
Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points
|
Mar 12 |
Why Caribou Biosciences Stock Is Crashing Today
|